Monthly Archives: May 2020

Pelangio Exploration Completes Final Tranche of Previously Announced Private Placement for Total Aggregate Gross Proceeds of Approximately $1,450,000

This news release is intended for distribution in Canada only and is not intended for distribution to United States newswire services or dissemination in the United States

TORONTO, ON / ACCESSWIRE / May 27, 2020 / Pelangio Exploration Inc. (TSXV:PX)(OTC PINK:PGXPF) ("Pelangio" or the "Company") is pleased to announce that it has closed the final tranche of the non-brokered private placement previously announced on May 7, 2020 and May 11, 2020 and May 19, 2020 (the "Offering"). In this final tranche, the Company raised aggregate gross proceeds of $715,900 (the "Final Tranche") by issuing 4,420,000 hard dollar units (the "HD Units") at a price of $0.12 per HD Unit and 1,325,000 common shares of the Company issued on a flow-through basis (the "FT Shares") at a price of $0.14 per FT Share. The total gross proceeds of the Offering, including the funds raised as part of the first tranche closed on May 19, 2020, consist of $1,449,900.

Each HD Unit consists of one common share of the Company (a "Common Share") and one Common Share purchase warrant ("Warrant"). Each Warrant entitles the holder to purchase one Common Share at a price of $0.18 for a period of two years from May 19, 2020 (the "Initial Closing Date"). The FT Shares will qualify as "flow-through shares" (within the meaning of the Income Tax Act (Canada)).

The gross proceeds from the sale of the FT Shares will be used to incur qualifying Canadian Exploration Expenses. Qualifying expenses are to be incurred by no later than December 31, 2021 for renunciation to investors of FT Shares in the Offering effective December 31, 2020. The balance of the proceeds of the Offering will be used for general corporate and working capital purposes, and for the development of the Company's mining projects.

In connection with the closing of the Final Tranche, the Company paid finder's fees to Canaccord Genuity Corp., PI Financial Corp., and Leede Jones Gable Inc., each arm's length finders, consisting of an aggregate of $5,530 in cash and an aggregate of 40,250 non-transferrable warrants ("Finder Warrants"). Each Finder Warrant issued under the Offering entitles the holder to purchase one Common Share at a price of $0.18 for a period of two years from the Initial Closing Date.

The purchase of HD Units and FT Shares pursuant to the Offering by Ingrid Hibbard (President, CEO, and a director of the Company) and David Mosher (a director of the Company) (collectively, the "Related Parties") constituted a "related party transaction" as such term is defined by Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company was exempt from the MI 61-101 valuation and minority approval requirements for related party transactions in connection with the Offering under sections 5.5(a) and 5.7(1)(a) of MI 61-101 as neither the fair market value (as determined under MI 61-101) of the subject matter of, nor the fair market value of the consideration for, the transaction, insofar as it involves the Related Parties, exceeds 25% of the Company's market capitalization (as determined under MI 61-101).

All securities issued in the Final Tranche of the Offering, including the Finder Warrants, are subject to a statutory hold period expiring on September 28, 2020. The Offering remains subject to final acceptance by the TSX Venture Exchange.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities in any jurisdictions in which such offer, solicitation or sale would be unlawful. Any offering made will be pursuant to available prospectus exemptions and restricted to persons to whom the securities may be sold in accordance with the laws of such jurisdictions, and by persons permitted to sell the securities in accordance with the laws of such jurisdictions.

About Pelangio

Pelangio acquires and explores land packages in world-class gold belts in Canada and Ghana, West Africa. In Canada, the company is focusing on the 6.7 km2 Grenfell property located approximately 10 km from the Macassa Mine in Kirkland Lake, the Dome West property located 800 metres from the Dome Mine in Timmins, the 25 km2 Birch Lake Property located in the Red Lake Mining District and the Dalton Property located 1.5 km from the Hollinger Mine in Timmins. In Ghana, the Company is focusing on two 100% owned camp-sized properties: the 100 km2 Manfo Property, the site of seven recent near-surface gold discoveries, and the 284 km2 Obuasi Property, located 4 km on strike and adjacent to AngloGold Ashanti's prolific high-grade Obuasi Mine. Ghana is an English speaking, common law jurisdiction that is consistently ranked amongst the most favourable mining jurisdictions in Africa.

For additional information, please visit our website at www.pelangio.com, or contact:

Ingrid Hibbard, President and CEO
Tel: 905-336-3828 / Toll-free: 1-877-746-1632 / Email: info@pelangio.com

Forward Looking Statements

Certain statements herein may contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Forward-looking statements or information appear in a number of places and can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate" or "believes" or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements and information include statements regarding the Offering generally, the proposed use of proceeds and the Company's exploration plans. With respect to forward-looking statements and information contained herein, we have made numerous assumptions, including assumptions about the state of the equity markets. Such forward-looking statements and information are subject to risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statement or information. Such risks include receipt of final approval for the Offering from the TSX Venture Exchange, the Company's ability to conduct our exploration programs as planned, changes in equity markets, share price volatility, volatility of global and local economic climate, gold price volatility, political developments in Ghana, increases in costs, exchange rate fluctuations, speculative nature of gold exploration and other risks involved in the gold exploration industry. See the Company's annual and quarterly financial statements and management's discussion and analysis for additional information on risks and uncertainties relating to the forward-looking statement and information. There can be no assurance that a forward-looking statement or information referenced herein will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements or information. Also, many of the factors are beyond the control of the Company. Accordingly, readers should not place undue reliance on forward-looking statements or information. We undertake no obligation to reissue or update any forward-looking statements or information except as required by law. All forward-looking statements and information herein are qualified by this cautionary statement.

SOURCE: Pelangio Exploration Inc.

ReleaseID: 591656

Sparta Capital Announces Proposed Private Placement

Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

CALGARY, AB / ACCESSWIRE / May 27, 2020 / Sparta Capital Ltd. (TSXV:SAY) (the "Corporation" or "Sparta") announces that the Corporation intends to complete a non-brokered private placement (the "Offering") utilizing the TSX Venture Exchange's Temporary Relief Bulletin dated April 8, 2020.

Pursuant to the Offering, Sparta will issue up to 10,000,000 units ("Units") of the Corporation at a price of $0.025 per Unit for gross proceeds of up to $250,000.00. Each Unit will be comprised of one common share ("Common Share") and two-half of one Common Share purchase warrants of the Corporation, with one-half of one Common Share purchase warrant priced at $0.05 per Common Share ("5 Cent Half Warrant") and one-half of one Common Share purchase warrant priced at $0.10 per Common Share ("10 Cent Half Warrant"), thus representing $0.05 per common share on a fully diluted basis. For the purposes of the Offering for Units a reference to a "Warrant" refers to both: (a) two 5 Cent Half Warrants, and (b) two 10 Cent Half Warrants. Each Warrant will entitle the holder thereof to acquire an additional Common Share at a price of $0.05 or $0.10, as applicable, for up to twenty-four (24) months following closing. The Corporation intends to use the net proceeds to; a) expand marketing and communications efforts (25%), b) acquire products to assist the expansion of sales for both the TruckSuite™ and TreeFrog™ brand (40%), and c) cover general working capital for general corporate purposes that includes, audit, legal, accounting, license and fees, administration, management, office, travel and promo (35%). Should the maximum Offering not be achieved, the use of proceeds will be adjusted by the Corporation. There is no minimum Offering. The Offering is subject to certain conditions including but not limited to, the receipt of all necessary approvals including the approval of the TSX Venture Exchange Inc. ("TSXV"). Pursuant to applicable securities laws, all securities issued pursuant to the Offering will be subject to a four-month hold period from the date of closing.

About Sparta™

Sparta Group is a company that owns or holds a controlling interest in a network of independent businesses that supply energy saving technologies designed to reduce energy inefficiencies, achieve reduced emissions, and increase operating efficiencies in various industries. Sparta's network of independent businesses provides a wide range of specialized energy capturing, converting, optimizing, and related services to the commercial sector. Sparta provides capital, technical and engineering expertise, legal support, financial and accounting knowledge, strategic planning and other shared services to its independent businesses.

Sparta is a publicly traded company listed on the TSX Venture Exchange Inc. under the symbol "SAY" (TSX.V: SAY). Additional information is available at www.spartagroup.ca or on SEDAR at www.sedar.com.

For further information please contact:

John O'Bireck, President
Email: jobireck@spartagroup.ca
Telephone: (905) 751-8004

Cautionary Statements:

This news release contains "forward-looking information" within the meaning of applicable securities laws. When used in this news release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although the Corporation believes in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, readers are cautioned to not place undue reliance on forward-looking information because the Corporation can give no assurance that they will prove to be correct. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date of publication of this news release and the Corporation undertakes no obligation to update such forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Furthermore, the Corporation undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Corporation. In particular, this news release contains forward-looking statements relating to, among other things, statements pertaining to the "Offering" and actual results could differ materially from those currently anticipated due to a number of factors and risks.

These include, but are not limited to, the failure to obtain necessary regulatory approvals, necessary financing and risks associated with the environmental technologies industry in general. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Sparta Capital Ltd.

ReleaseID: 591604

ProLung Announces Corporate Name Change to IONIQ Sciences to Reflect Expanded Early Cancer Detection Strategy

SALT LAKE CITY, UT / ACCESSWIRE / May 27, 2020 / IONIQ Sciences Inc. ("IONIQ Sciences" or the "Company"), which is changing the cancer landscape with a modern multi-cancer screening technology using its non-invasive Electrical Impedance Analytics (EIA) technology and a proprietary algorithm, announced it is changing its name from ProLung, Inc. to IONIQ Sciences, Inc. (dba). The new corporate name – IONIQ Sciences – reflects its mission to dramatically improve the cancer landscape with a modern solution for the early detection of multiple cancers thereby expanding the therapeutic window, significantly improving survivability, and reducing the cost of healthcare.

IONIQ Sciences remains fully committed to gaining U.S. FDA regulatory clearance and subsequently commercializing the IONIQ ProLung Test™ for lung cancer. The ProLung Test, which was recently awarded Breakthrough Device Designation by the FDA, is the foundation upon which IONIQ Sciences will expand its platform technology into a modern multi-cancer screen for early detection. The external clinical validation results and internal discoveries suggest IONIQ's technology is measuring the body's early warning system to the presence and localities of cancer malignancies. To that end, IONIQ Sciences initiated an IRB-approved feasibility study on breast cancer at the beginning of 2020.

IONIQ Sciences invites new and potential investors, family, friends and partners to visit its new website at www.IONIQsciences.com. The name change to IONIQ Sciences, Inc. is effective immediately.

About IONIQ Sciences, Inc.

IONIQ Sciences, Inc. is developing advanced multi-cancer screening technology for early detection that will expand the therapeutic window, dramatically improve survivability and reduce the cost of healthcare. IONIQ Sciences operates at the confluence of its Electrical Impedance Analytics (EIA) technology and artificial intelligence (AI). IONIQ Science's first product utilizing its proprietary analytic platform, the ProLung Test™ for lung cancer, has been designated a Breakthrough Device by the U.S. FDA. ProLung rebranded to IONIQ Sciences in May 2020.

Forward-Looking Statements

Statements contained in this release that are not purely historical, including, without limitation statements regarding IONIQ Sciences' future performance and goals, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties such as those described in the IONIQ Sciences' Annual Report on Form 10-K for the year ended December 31, 2017 and subsequent filings with the Securities and Exchange Commission. Such risks and uncertainties include inherent risks and uncertainties relating to IONIQ Sciences' ability to meet its funding requirements for its operations and other commitments and to obtain successful test results and regulatory approvals for its products. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections.

For further information about IONIQ Sciences, Inc., please contact:

Andy Robertson | 1-801-503-9231| acr@IONIQsciences.com
IONIQ Sciences, Inc., Vice President of Business Development
IONIQ Sciences, Inc.
350 W. 800 N., Suite 214
Salt Lake City, Utah 84103
USA
www.IONIQsciences.com

Follow IONIQ Sciences, Inc. on Twitter, Facebook and LinkedIn: @IONIQScience

SOURCE: ProLung, Inc.

ReleaseID: 591663

Hemptown Announces New Advisory Board Members

VANCOUVER, BC / ACCESSWIRE / May 27, 2020 / Hemptown Organics Corp ("Hemptown" or the "Company"), is pleased to announce the appointment of Janice Knox and Siddhartha "Sid" Senroy to the Hemptown Advisory Board.

Dr. Janice Knox is a board-certified anesthesiologist. Janice continues to be a much sought-after keynote speaker for cannabis therapeutics domestically and internationally. Dr. Knox is a co-founder of The American Cannabinoid Clinics and ADVENT Academy. She firmly believes that cannabinoid care starts with the understanding of the intricate and complex physiology of the Endocannabinoid System (ECS). Knowledge is rapidly changing as more research uncovers the depth of the ECS. Dr. Janice is a board member of the American Academy of Cannabinoid Medicine (AACM) and Co-founder of the Products with Purpose Initiative, an initiative working to create a standard of products based on the pharmacology of cannabis and the physiology of the ECS. The initiative pushes for the philosophy of conscientious capitalism which takes into consideration the environment, social consciousness and responsibility, products created based on science to the efficacy and affordability to the end consumer. Along with her teammates at The American Cannabinoid Clinics, Dr. Knox believes in an integrative approach to delivering medical cannabis care that is rooted in evidence-based Lifestyle and Functional Medicine.

Sid Senroy has an MBA from Pepperdine University and with this foundation, has been able to successfully navigate the business world. Over the last 2 decades, Sid has led several global quality and compliance business units as an executive or as a senior consultant leading to approvals of key blockbuster pharmaceuticals. The cumulative sales of these drugs have exceeded $20 billion annually over the last 10 years. Sid specializes in helping companies pass compliance assessments, develop robust quality systems, and prepare for FDA reviews and inspections. His leadership skills enable him to form cross-functional alliances for improvement and growth. His sensitivity to cultural nuances has helped him to succeed on a global scale. He has worked extensively in Russia, India, Poland, Ukraine, China, Japan, South Africa, and Australia to name a few countries.

"We are excited for what the future holds for Hemptown. We strongly believe with the help of our highly equipped Advisory Board, that we will take the Company to new heights in 2020 and beyond," said Eric Gripentrog, CEO of Hemptown. "These two exceptional individuals are at the forefront of their respective industries, and we know with their support and expertise that we will enhance our products and services, ultimately increasing Hemptown's reach globally."

About Hemptown Organics Corp.

Hemptown is growing some of the finest hemp in the world to meet the global demand for cannabinoid-based products. Farmland spanning three states, product manufacturing capability and a strong leadership team are the pillars for Hemptown's growth model as the Company pushes into the consumer-packaged goods sectors with top quality white label and branded product lines for the consumer market. Hemptown's fully operational (FDA-licensed and cGMP certified) nutraceutical manufacturing facility in Oregon gives the company a strong leadership position in a global market that continues to grow exponentially. For more information, visit www.hemptownusa.com.

Hemptown Investor Relations

info@hemptownusa.com
604-200-5969

Disclaimer for Forward-Looking Statements

This news release contains forward-looking statements that involve various risks and uncertainties regarding future events. Such forward-looking statements are based on current expectations of management, involve a number of risks and uncertainties, and are not guarantees of future performance of Hemptown (the company). These statements generally can be identified by the use of forward-looking words such as "may", "should", "will", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the closing date of the financing, the attributes of the securities to be offered and sold by the Company, the proposed use of the net proceeds of the Offerings. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors that may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include general market conditions, significant business, competitive, political and social risks and other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

SOURCE: Hemptown Organics Corp.

ReleaseID: 591676

Wise to the Future, LTG Shocks the World

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / The advent of the Internet era enables the development of big data usher in explosive growth, however, when we enjoy the convenience, we also bear a lot of risks. It is often lamented that this is an era of nudity without privacy, the advent of Internet crawlers, human flesh search and other means puts people's lives under a variety of microscopes, and economic fraud reports because of the disclosure of information are also common.

However, science and technology lead the development of the times, where there are problems, there are countermeasures!

To this end, LTG has brought together the world's top talents in blockchain, 5G, digital assets and other fields, linked various resources, inventively designed the "blockchain + 5G + data storage" three-in-one ecological model, and built a complete ecosystem based on the physical data storage business to serve the public.

LTG's initiative to redefine the secure utility of data storage is an open-source public chain that the Kyrgyzstan LTG Foundation has invested heavily and has been successfully developing for more than a year. LTG uses blockchain and 5G and other high-techs to record and store the data produced by the participants of the Internet of Things in the whole society, and creates a brand-new data generation and application ecology with blockchain technology as the core, so as to improve the value of the data itself and improve the data base space.

LTG blockchain storage technology is a fragmented and multi-backup repair technology to decentralize storage; and therefore, the uploaded video, pictures, and files are more private. And LTG distributed server network disk cloud storage supports government cloud, enterprise cloud, medical cloud, personal information and other cloud storage applications.

Based on the development of existing cloud storage technology, LTG has made a lot of innovations, fully combined with cloud computing and 5G technology. In the future, it will realize the edge storage closer to users, users can store the file data on the nearest node by point-to-point method, and without the central server, zero distance to users can also be realized so that the speed will be the fastest no matter for uploading files or extracting files. With AI intelligent system, each hard disk space can be allocated efficiently by LTG, and the flexibility of cloud computing and time space can be realized. Meanwhile, through the block map, LTG can query the distribution of your stored information in the mining machine.

LTG has completed the encryption of information transmission, information permanence and data storage and interoperability. It is committed to providing a secure, convenient, efficient and stable distributed data storage solution for the public, creating an all-round new ecology of data storage, connecting digital currency with the real world through blockchain, enriching the application scenarios of 5G technology and data storage, and promoting its service to commercial progress and social development.

This is LTG. This is just the beginning! As 5G and blockchain technology spread, LTG is expected to realize "Internet of Everything", construct a digital social and economic environment, and realize the ecological vision of "co-construction, co-ownership, interconnection and intercommunication"!

Contact:

LTG
Erkaiym Bai
++9960777833333
http://www.ltgcoin.vip/

SOURCE: LTG

ReleaseID: 591677

FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against HF Foods Group Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 27, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HF Foods Group Inc. ("HF Foods" or "the Company") (NASDAQ:HFFG) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. HF Foods is the subject of a research report released by Hindenburg Research on March 23, 2020. According to the report, the Company engaged in "massive undisclosed related-party transactions." The report alleges that shareholder money was "spent on exotic supercars," and that the Company had an "outrageous fundamental valuation." Based on this news, shares of HF Foods fell sharply in intraday trading.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 591670

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SERV, IQ and CTMX

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Servicemaster Global Holdings, Inc. (NYSE:SERV)
Class Period: February 26, 2019 – November 4, 2019
Lead Plaintiff Deadline: June 9, 2020

According to the complaint, Servicemaster Global Holdings, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) ServiceMaster had failed to properly inspect and treat for Formosan termite activity; (b) as a result thereof, the Company was and continued to experience a material adverse trend of costly litigation from injured customers which was not disclosed to investors; (c) in an unsuccessful attempt to mitigate this trend, Defendants had been taking remedial measures since at least 2018, including drastically raising prices for termite treatments in Mobile, Alabama to deter contract renewals; and (d) as a result of the foregoing, ServiceMaster's financial results were reasonably likely to be impacted, and would continue to impact the Company into 2020.

Learn about your recoverable losses in SERV: http://www.kleinstocklaw.com/pslra-1/servicemaster-global-holdings-inc-loss-submission-form?id=6937&from=1

iQIYI, Inc. (NASDAQ:IQ)
The IQ lawsuit is on behalf of persons and entities other than Defendants that purchased or otherwise acquired: (a) iQIYI American Depository Shares pursuant and/or traceable to the Company's initial public offering conducted on or about March 29, 2018; or (b) iQIYI securities between March 29, 2018, and April 7, 2020.
Lead Plaintiff Deadline: June 15, 2020

The complaint alleges that throughout the class period iQIYI, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) iQIYI inflated its revenue figures; (2) iQIYI inflated its user numbers; (3) iQIYI inflated its expenses to cover up other fraud; and (4) as a result, Defendants' public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in IQ: http://www.kleinstocklaw.com/pslra-1/iqiyi-inc-loss-submission-form?id=6937&from=1

CytomX Therapeutics, Inc. (NASDAQ:CTMX)
Class Period: May 17, 2018 – May 13, 2020
Lead Plaintiff Deadline: July 20, 2020

The complaint alleges CytomX Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program; (ii) CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in CTMX: http://www.kleinstocklaw.com/pslra-1/cytomx-therapeutics-inc-loss-submission-form?id=6937&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 591665

Paragon Calls on AeroCentury Corp. to Postpone Uncertain Annual Meeting

ATLANTA, GA / ACCESSWIRE / May 27, 2020 / Paragon Technologies, Inc. (OTC PINK:PGNT), one of the largest shareholders of AeroCentury Corp., has called on AeroCentury Corp. (NYSE American:ACY) to delay its hastily called and uncertain 2020 annual meeting to give shareholders the full and fair opportunity to nominate director candidates for election to the board of directors.

AeroCentury announced on May 5, 2020 that it has entered into a forbearance agreement with its principal lenders that requires the company to take action to effectuate a forced strategic transaction or face an immediate event of default. In addition, AeroCentury disclosed on May 14, 2020 that it is delaying the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2020 beyond the regular filing deadline.

AeroCentury delayed its annual meeting from the usual timing of early May and abruptly filed and mailed a proxy statement on May 1, 2020 for a proposed annual meeting on June 9, 2020. Surprisingly, AeroCentury informed shareholders that it "may determine that it is in the best interest of our stockholders to change the date, time or location of the 2020 Annual Meeting of Stockholders," causing uncertainty as to when and if the annual meeting will actually be held.

In light of the significant developments in AeroCentury's financial circumstances and the actions taken by its board, Paragon calls on the board to postpone the annual meeting for a period of at least 90 days from the currently scheduled date to allow shareholders a reasonable opportunity to offer alternative director candidates for shareholders to vote on. In this regard, Paragon has provided potential director candidates to the board for consideration.

"AeroCentury today, we believe, is on the verge of bankruptcy," noted Sham Gad, Chairman and CEO of Paragon Technologies, "On May 15, we delivered a letter to the AeroCentury board outlining the dire financial and operational concerns the company is facing."

"More so, we believe shareholder rights are being neglected by various corporate governance issues including the staggered board terms that elects directors for three years. The Company needs a fresh perspective and a new vision if there is going to be any equity value remaining at the end of day. For months, we have tried to proactively and constructively engage with the Board and management, only to be ignored while watching the ship sink deeper and deeper into an abyss."

Mr. Gad further states, "We have presented ACY with candidates that offer the qualifications and experience that can help deliver a new plan that drives success for all stakeholders. But time is quickly running out. We appreciate the confidence and support we have gotten from existing shareholders and we are ready to begin the hard and challenging job of transforming ACY into a specialized profitable aircraft lessor serving a more lucrative market."

If you are a shareholder of AeroCentury, we would like to hear from you. Please contact Sham Gad, the Chairman and President of Paragon, at info@pgntgroup.com so that we can provide you with additional information regarding our efforts to facilitate shareholder input and effectuate positive change at AeroCentury.

Contact:

Paragon Technologies, Inc.
Sham M. Gad
706-340-4817
info@pgntgroup.com

SOURCE: Paragon Technologies, Inc.

ReleaseID: 591654

LAWSUITS FILED AGAINST MESA, EHTH and CONN – JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Mesa Air Group Incorporated (NASDAQ:MESA)

CONTACT JAKUBOWITZ ABOUT MESA:
https://claimyourloss.com/securities/mesa-air-group-incorporated-loss-submission-form/?id=6934&from=1

Lawsuit on behalf of: investors who purchased MESA shares pursuant and/or traceable to the documents issued in connection with Mesa Air Group's August 2018 initial public offering.

Lead Plaintiff Deadline: June 1, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Mesa Air Group's operational performance was poor and below industry standards; (2) Mesa Air Group had a shortage of qualified mechanics and maintenance personnel; (3) Mesa Air Group had an inadequate number of spare aircraft and parts; (4) Mesa Air Group did not have a strong track record of reliable performance; (5) then-existing "risks" had already materialized; (6) Mesa Air Group knew of undisclosed adverse trends and uncertainties at the time of the initial public offering; and (7) as a result, Defendants' public statements were materially false and misleading at all relevant times.

eHealth, Inc. (NASDAQ:EHTH)

CONTACT JAKUBOWITZ ABOUT EHTH:
https://claimyourloss.com/securities/ehealth-inc-loss-submission-form/?id=6934&from=1

Class Period: March 19, 2018 – April 7, 2020

Lead Plaintiff Deadline: June 8, 2020

The complaint alleges that eHealth, Inc. issued materially false and/or misleading information and/or failed to disclose: (1) its highly aggressive accounting and modeling assumptions; (2) its skyrocketing rate of member churn, resulting from eHealth's pursuit of low quality, lossmaking growth; (3) its reliance on direct response television advertising, which attracts an unprofitable, high churn enrollee; and (4) that as a result of the foregoing, defendants' public statements were materially false and misleading at all relevant times.

Conn's, Inc. (NASDAQ:CONN)

CONTACT JAKUBOWITZ ABOUT CONN:
https://claimyourloss.com/securities/conns-inc-loss-submission-form/?id=6934&from=1

Class Period: September 3, 2019 – December 9, 2019

Lead Plaintiff Deadline: July 14, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Conn's was experiencing an increase in first payment defaults and 60-plus day delinquencies; (2) as a result, Conn's was reasonably likely to record an increase to its provision for bad debts; (3) the Company made certain underwriting adjustments, including tightening its standards for new customers and online applicants; (4) as a result, the Company's same-store sales would be adversely impacted; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law

ReleaseID: 591657

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VMW, FITB and GSX

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

VMware, Inc. (NYSE:VMW)
Class Period: March 30, 2019 – February 27, 2020
Lead Plaintiff Deadline: June 1, 2020

VMware, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) VMware's reporting with respect to its backlog of unfilled orders was not in compliance with all relevant accounting and disclosure requirements; (ii) the foregoing subjected the Company to a foreseeable risk of heightened regulatory scrutiny and/or investigation; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in VMW: http://www.kleinstocklaw.com/pslra-1/vmware-inc-loss-submission-form?id=6932&from=1

Fifth Third Bancorp (NASDAQ:FITB)
Class Period: February 26, 2016 – March 6, 2020
Lead Plaintiff Deadline: June 8, 2020

The FITB lawsuit alleges that throughout the class period, Fifth Third Bancorp made materially false and/or misleading statements and/or failed to disclose that: (i) as a result of Fifth Third Bank's aggressive incentive policies to promote its cross-sell strategy, Fifth Third Bank employees engaged in unauthorized conduct with customer accounts; (ii) since at least 2008, Fifth Third Bank, and by extension, Fifth Third, was aware of such unauthorized conduct and, thus, that it was violating relevant regulations and laws aimed at protecting its consumers; (iii) Fifth Third failed to properly implement and monitor its cross-sell program, detect and stop misconduct, and identify and remediate harmed consumers; (iv) all the foregoing subjected the Company to a foreseeable risk of heightened regulatory scrutiny or investigation; (v) Fifth Third's revenues were in part the product of unlawful conduct and thus unsustainable; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in FITB: http://www.kleinstocklaw.com/pslra-1/fifth-third-bancorp-loss-submission-form?id=6932&from=1

GSX Techedu Inc. (NYSE:GSX)
Class Period: June 6, 2019 – April 13, 2020
Lead Plaintiff Deadline: June 16, 2020

During the class period, GSX Techedu Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) GSX overstated its profitability, revenue, student enrollment figures, teacher qualifications, and teacher selection process; (ii) the foregoing, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in GSX: http://www.kleinstocklaw.com/pslra-1/gsx-techedu-inc-loss-submission-form?id=6932&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 591655